Pacer Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Pacer Advisors, Inc. holds 27,192 shares of TAK stock, worth $365,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,192
Previous 27,057
0.5%
Holding current value
$365,460
Previous $384,000
6.25%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding TAK
# of Institutions
334Shares Held
68.5MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$177 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$62.2 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$56.7 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$45.8 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...